| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 32.29▲ | 32.29▲ | 32.29▲ | 33.14▼ | 32.87▲ |
| MA10 | 32.12▲ | 31.92▲ | 31.92▲ | 33.15▼ | 32.49▲ |
| MA20 | 31.76▲ | 31.70▲ | 31.70▲ | 32.96▲ | 31.80▲ |
| MA50 | 30.88▲ | 30.68▲ | 30.66▲ | 32.23▲ | 30.99▲ |
| MA100 | 29.50▲ | 29.24▲ | 29.16▲ | 31.74▲ | 30.23▲ |
| MA200 | N/A | N/A | N/A | 31.15▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.046▲ | 0.062▲ | 0.060▲ | -0.037▼ | 0.149▲ |
| RSI | 66.716▲ | 66.062▲ | 65.964▲ | 55.828▲ | 61.217▲ |
| STOCH | 89.254▲ | 92.184▲ | 92.184▲ | 54.574 | 85.957▲ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -54.543 | -11.010▲ |
| CCI | 150.669▲ | 168.562▲ | 168.562▲ | -18.331 | 108.195▲ |
|
Friday, January 09, 2026 08:41 AM
(RTTNews) - Camurus AB (CAMX.ST) has announced on Friday that the U.S. Food and Drug Administration has accepted to review their resubmission of New Drug Application for Oclaiz, an extended-release ...
|
|
Friday, January 09, 2026 06:36 AM
LUND, Sweden, Jan. 9, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/01/26 | 33.102 | 33.102 | 33.102 | 33.102 | 100 |
| 29/01/26 | 33.2455 | 33.2455 | 33.2455 | 33.2455 | 14 |
| 28/01/26 | 32.99 | 33.0024 | 32.99 | 33.0024 | 312 |
| 27/01/26 | 32.97 | 32.97 | 32.97 | 32.97 | 21 |
| 26/01/26 | 33.369 | 33.369 | 33.369 | 33.369 | 23 |
| 23/01/26 | 33.2497 | 33.2497 | 33.2497 | 33.2497 | 144 |
| 22/01/26 | 33.3602 | 33.3602 | 33.3602 | 33.3602 | 201 |
| 21/01/26 | 33.07 | 33.2699 | 33.03 | 33.2222 | 823 |
| 20/01/26 | 32.7703 | 32.7703 | 32.7703 | 32.7703 | 98 |
| 16/01/26 | 33.50 | 33.50 | 33.2201 | 33.2201 | 195 |
|
|
||||
|
|
||||
|
|